Dose adjustment in renal impairment
Dose adjustment may be needed in kidney disease.
Leaflet HEPARINE SODIQUE PANPHARMA 5000UI / ml solution for injection
Heparin is an anticoagulant used to prevent and treat thrombosis and pulmonary embolism, and during certain procedures including dialysis. It enhances antithrombin, a protein that limits blood clotting. It prevents new clots from forming and existing clots from growing, but does not dissolve them directly.
Injectable unfractionated heparin is given intravenously or under the skin, never into a muscle. Doses are prescribed individually; clotting tests and platelet counts may be needed. Heparin gels are used locally for bruises and symptoms involving superficial veins. They are applied to intact skin and do not replace injectable treatment.
The main risk of injectable heparin is bleeding. Bruising, injection reactions and occasionally an immune-related fall in platelets can occur. This reaction can paradoxically cause new clots; any previous episode must be reported before treatment. Gels may cause local irritation or allergy and must not be applied to wounds or bleeding areas.
Seek urgent help for persistent bleeding, black stools, blood in urine, a sudden severe headache, breathlessness or a suddenly swollen, painful leg. Do not add aspirin, ibuprofen or other anticoagulants without medical approval. Inform the doctor before procedures, including dental treatment or spinal anaesthesia, and do not change the dose yourself.
Injectable unfractionated heparin is given intravenously or under the skin, never into a muscle. Doses are prescribed individually; clotting tests and platelet counts may be needed. Heparin gels are used locally for bruises and symptoms involving superficial veins. They are applied to intact skin and do not replace injectable treatment.
The main risk of injectable heparin is bleeding. Bruising, injection reactions and occasionally an immune-related fall in platelets can occur. This reaction can paradoxically cause new clots; any previous episode must be reported before treatment. Gels may cause local irritation or allergy and must not be applied to wounds or bleeding areas.
Seek urgent help for persistent bleeding, black stools, blood in urine, a sudden severe headache, breathlessness or a suddenly swollen, painful leg. Do not add aspirin, ibuprofen or other anticoagulants without medical approval. Inform the doctor before procedures, including dental treatment or spinal anaesthesia, and do not change the dose yourself.
General data about HEPARINE SODIQUE PANPHARMA 5000UI / ml
- Substance:
- heparin
- Date of latest medicines list:
- 01-06-2017
- Product code:
- W03447001
- Concentration:
- 5000UI / ml
- Pharmaceutical form:
- solution for injection
- Quantity:
- 10
- Product type:
- Generic medicine
- Prescription status:
- S — Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.
Pharmaceutical forms available for heparin
Concentrations available for heparin
- 100000ui
- 2400UI/g
- 25.000U.I./5ml
- 25000UI/5ml
- 5000UI/ml
- 500UI/1g
- 500UI/ml
Combinations with other substances
Precautions:
Major drug interactions
This medicine may have important interactions with other medicines.
Additional monitoring
This medicine is subject to additional monitoring.
Breastfeeding warning
Use during breastfeeding only on medical advice.
Pregnancy warning
Use during pregnancy only on medical advice.
Bleeding risk
This medicine may increase the risk of bleeding.